Why the study?
Does muscle contraction attenuate neuropeptide Y-mediated vasoconstriction similarly to α1-adrenergic signalling in healthy adults?
Does muscle contraction attenuate neuropeptide Y-mediated vasoconstriction similarly to α1-adrenergic signalling in healthy adults?
Answers are grounded in this paper and cite their sources.
This editorial highlights first-in-human data demonstrating that neuropeptide Y-mediated vasoconstriction is attenuated by exercise-induced metabolic inhibition to a similar degree as α1-adrenergic signaling.
The ability to sustain dynamic skeletal muscle contractions requires matching blood flow delivery to metabolic demand (Joyner & Casey, 2015). But how do we ensure that the increase in cardiac output which accompanies exercise is directed towards contracting muscle? In general, this is accomplished through the balance of global increases in peripheral sympathetic outflow, which stimulates the release of norepinephrine causing α-adrenergic receptor mediated contraction of vascular smooth muscle (i.e. vasoconstriction), and increases in metabolites local to contracting muscle, which can cause vasodilatation and attenuate postjunctional sympathetic vasoconstrictor signalling in an exercise intensity-dependent manner (Joyner & Casey, 2015). This latter phenomenon, termed functional sympatholysis, is considered to be a critical pathway in ensuring adequate perfusion of contracting skeletal muscle (Joyner & Casey, 2015). However, despite considerable attention directed towards α-adrenergic signalling, sympathetic nerve terminals can also co-release neuropeptide Y (NPY), a more potent vasoconstrictor than norepinephrine, during periods of sustained high-frequency sympathetic nerve firing (Hodges et al., 2009). Our understanding of the role of NPY in regulating exercise blood flow in humans to date has been severely limited. In this issue of The Journal of Physiology, Wakeham et al. (2025) explore the capacity of muscle contraction to overcome the vasoconstrictor actions of NPY and compare the magnitude of responses between NPY and phenylephrine (PE), an α1-adrenergic agonist. Twelve healthy adults (n = 7 males) underwent intra-arterial catheterization of the brachial artery to permit the infusion of pharmacological agents and measurement of blood pressure. Doppler ultrasound was simultaneously employed to measure forearm blood flow, permitting the calculation of forearm vascular conductance as the primary study outcome to assess vasoconstrictor responsiveness. Measurements of heart rate, blood pressure, forearm blood flow and forearm vascular conductance were obtained at rest, during steady state rhythmic handgrip exercise at 15% maximal voluntary contraction, as well as during handgrip exercise with parallel infusion of NPY or PE. To confirm that any attenuations in vasoconstrictor responsiveness were a result of metabolic inhibition, additional NPY and PE infusion trials were completed using sodium nitroprusside (instead of exercise) to produce non-metabolic vasodilatation. A key strength of the study was the completion of a NPY dose response protocol that enabled researchers to identify the NPY dose required to elicit a similar, ∼30% reduction in forearm vascular conductance, as PE. Overall, the results of the study support the hypothesis that NPY-mediated vasoconstriction is sensitive to metabolic inhibition caused by muscle contraction and demonstrate that the magnitude of sympatholysis does not differ between NPY and α1-adrenergic signalling (PE: 57 ± 32% vs. NPY: 50 ± 36%). The present data are the first of their type in humans and stimulate several avenues for discussion and future study. First, whether the results from exogenous NPY infusions can be translated to endogenous NPY contributions to exercise blood flow regulation remains difficult to determine at this time because of the lack of available antagonists. A better understanding of NPY release during exercise might be an important first step. Prior work reported that ≥20 min of constant load cycling at 60% peak oxygen uptake rate is needed to increase NPY, whereas 12 min of static handgrip exercise, a potent stimulus to increase muscle sympathetic nerve activity, did not (Pernow et al., 1986). The time-course of such data suggest that closed-loop protocols designed to test functional sympatholysis in humans (e.g. lower body negative pressure with and without exercise) are probably of insufficient duration to involve significant NPY-mediated vasoconstriction and may be more specific to α-adrenergic signalling. Developing a model to test functional sympatholysis of endogenous NPY and α1-adrenergic vasoconstriction in different populations is a vital next step to parse out their respective contributions to exercise blood flow regulation. Second, whether the vascular effects of NPY are influenced by biological sex will be important to understand. Sex differences in the firing frequency of sympathetic nerves could contribute to differing endogenous NPY release (Hodges et al., 2009), whereas, more applicable to the present study, data from isolated tail artery ring segments found a greater contractile response to NPY in female vs. male rats as a result of female and male sex hormones enhancing and suppressing NPY responsiveness, respectively (Glenn et al., 1996). Albeit, these sex-dependent differences are not consistent between studies (Hodges et al., 2009). Third, an interesting observation from the dose response protocol was paradoxical vasodilatation in 42% of participants at the lowest four doses (0.02–0.4 nmol min−1). Wakeham et al. (2025) speculate that NPY degradation products could stimulate histamine mediated vasodilatation, a hypothesis which could be tested in humans using over-the-counter histamine receptor blockade. Alternatively, work has suggested the existence of two NPY receptor subtypes in the vasculature, where postjunctional Y1 receptors potentiate vascular smooth muscle contraction, whereas prejunctional Y2 receptors attenuate α-adrenergic vasoconstriction (Glenn et al., 1996). Whether NPY receptor affinity is mediated by dose, akin to the greater affinity of epinephrine with β2-adrenergic receptors at low concentrations but α-adrenergic receptors at high concentrations, warrants further investigation. Fourth, impaired functional sympatholysis has been reported in several clinical populations, including hypertension and heart failure, and may contribute to the development of exercise intolerance (Joyner & Casey, 2015), an important risk factor for mortality. Whether metabolic inhibition of NPY-mediated vasoconstriction is diminished in these clinical cohorts to a similar degree as α-adrenergic signalling represents an important area for future study that may help direct future therapies. The study by Wakeham et al. (2025) represents an exceptional example of the utility and impact of small scale human integrative physiology studies. The results will now stimulate future work, including the investigation of putative metabolites that can interact with NPY signalling. Collectively, we hope these results stimulate a greater interest in understanding the contributions of NPY to circulatory control and lead to a more complete model of how sympathetic vasoconstriction is modulated in active skeletal muscle during exercise. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article. No competing interests declared. J.C.B. and P.J.M. were responsible for the conception or design of the work, drafting the work or revising it critically for important intellectual content, and approving the final version of the manuscript submitted for publication. Both authors agree to be accountable for all aspects of the work. JCB is supported by an Ontario Graduate Scholarship. PJM is supported a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant.
No takes yet. Share an insight, caveat, or question.
Bommarito et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: